ACTA1 and Myotonia: An important step was taken by Wheeler et al., who showed that subcutaneous injections of chimeric ASOs composed of 2′-MOE ends with a central gap of unmodified nucleotides targeting various regions of ACTA1 transcripts reduced CUG-expanded RNAs up to 80% in HSALR mice and almost eliminated myotonia [95].